While no definitive statistics exist, doctors say he was likely the longest-surviving intubated Covid patient.
Source: New York Times
Marc Lewitinn, 76, Covid Patient, Dies After 850 Days on a Ventilator
Published in Coronavirus (2019-nCoV), Deaths (Obituaries), Lewitinn, Marc (1946-2022), Medical Devices, Ventilators (Medical) and Weill Cornell Medical College
More from Coronavirus (2019-nCoV)More posts in Coronavirus (2019-nCoV) »
- Mamdani was elected with a thinner résumé than his predecessors as mayor.
- Mamdani’s Debate Guests Include Charlotte Bennett, a Cuomo Accuser
- New Jersey Is the Latest State to Expand Access to Updated Covid Shots
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Is It Covid? The Flu? RSV? New Yorkers Are Sick of Being Sick.
More from Deaths (Obituaries)More posts in Deaths (Obituaries) »
- Arthur L. Carter, 93, Dies; Investment Banker Founded a Cheeky Newspaper
- John Noble Wilford, Times Reporter Who Covered the Moon Landing, Dies at 92
- Robert B. Fiske Jr., First to Lead Whitewater Investigation, Dies at 94
- Mel Leipzig, Painter Called the ‘Chekhov of Trenton,’ Dies at 90
- James Riches, Fire Chief Who Lost Firefighter Son on 9/11, Dies at 74
More from Medical DevicesMore posts in Medical Devices »
- The Rationing of a Last-Resort Covid Treatment
- ‘There Was Nothing Anybody Could Do for These Patients.’ Now There Is.
- New York Spent $1 Billion on Virus Supplies. Now It Wants Money Back.
- The U.S. Has Lots of Ventilators — but Too Few Specialists to Mind Them
- Covid 'Testing Hell': Devices Given to Nursing Homes Bring New Problems
More from Ventilators (Medical)More posts in Ventilators (Medical) »
- Catching Up With One of the First Covid Patients to Be Put on a Ventilator
- Liesbeth Stoeffler, 61, Runner Kept Going by Rare Lung Treatment, Dies
- New York Spent $1 Billion on Virus Supplies. Now It Wants Money Back.
- The U.S. Has Lots of Ventilators — but Too Few Specialists to Mind Them
- 51 Days on a Ventilator: How ‘Miracle Larry’ Survived Covid-19
Be First to Comment